HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
HIV, tuberculosis (TB) and sexually transmitted infections (STIs) remain major public health challenges. Many affect the same communities and need joined-up prevention, testing and treatment.
The HIV/AIDS, Tuberculosis and Sexually Transmitted Infections session at GCPE 2027 covers research on these infections. It links closely with infectious diseases and outbreak management, which looks at infection control more broadly.
HIV, TB and STIs still affect millions of people worldwide. Many cases go undiagnosed, allowing infections to spread. Effective prevention and treatment exist but do not reach everyone. Stigma remains a major barrier to care.
Key Topics in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
• HIV prevention and PrEP
• HIV testing and treatment
• TB detection and treatment
• Drug-resistant TB
• TB and HIV co-infection
• Syphilis and congenital syphilis
• Gonorrhoea and antimicrobial resistance
• Stigma and access to services
• Key and vulnerable populations
• Global targets and elimination
Recent Advances in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
Long-acting PrEP and treatment are making HIV prevention easier. New shorter TB treatments are improving cure rates, and better tests from preventive medicine and public health microbiology are finding more cases.
Rising syphilis rates are a concern in many countries, linked with women’s and reproductive health. Reducing stigma is central, a theme in health equity and social determinants of health.
New prevention tools are reducing HIV infections. Shorter TB treatments are making cure easier to achieve. Testing services are reaching more people through community and self-testing. Global targets are driving progress towards elimination.
Who Should Attend the HIV/AIDS, Tuberculosis and Sexually Transmitted Infections Session
• HIV, TB and sexual health clinicians
• Public health practitioners
• Epidemiologists
• Community organisations
• PhD students and early-career researchers
• Programme managers
Why Present Your Research in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
Presenting at GCPE 2027 lets you share research with an international audience. You can connect with colleagues in global health and international healthcare systems working on global elimination targets. These infections need coordinated action. Your work can help programmes reach global goals.
Frequently Asked Questions
Can I present PrEP programme data?
Yes. HIV prevention programmes are welcome.
Does this session cover drug-resistant TB?
Yes. Drug-resistant TB is a key topic.
When and where is GCPE 2027?
GCPE 2027 takes place from 17 to 19 May 2027 at Delta Hotels Heathrow Windsor, London, UK, and online.